Error loading player: No playable sources found
2210
Changing the Status Quo on the Detection and Management of Barrett's Esophagus
Date
May 18, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Full DDW 2024 On Demand Program available now!
SOCIETY: AGA Risk stratification and screening of Barrett's esophagus: What's new?
Presentations:
| IN BARRETT'S ESOPHAGUS, REFLUX INDUCES FEATURES OF EPITHELIAL-MESENCHYMAL PLASTICITY MEDIATED BY APE/REF-1 REDOX FUNCTION: EVIDENCE FROM STUDIES IN BARRETT'S PATIENTS AND ORGANOIDS |
| BEYOND TFF3: IDENTIFYING NON-ENDOSCOPIC DNA METHYLATION BIOMARKERS FOR IMPROVED DIAGNOSIS OF BARRETT'S ESOPHAGUS |
| VALIDATION OF RISK ASSESSMENT TOOLS FOR THE DETECTION OF BARRETT’S ESOPHAGUS IN PATIENTS WITHOUT CHRONIC REFLUX SYMPTOMS |
| UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT’S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION |
| NONENDOSCOPIC DETECTION OF BARRETT'S ESOPHAGUS IN PATIENTS WITHOUT GERD SYMPTOMS |
| DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING (ML) BASED DECISION-MAKING TOOL TO DETERMINE RISK AND TIMING OF RECURRENCE OF BARRETT’S ESOPHAGUS (BE) NEOPLASIA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET) |
Moderators
VA Greater Los Angeles Healthcare System
Cleveland Clinic London
Speakers
Johns Hopkins Hospital
General
Tracks
Related Products
Updates in Barrett's Esophagus
LIVE STREAM SESSION This AGA session on Barrett's esophagus will provide a state of the art update on screening, surveillance and endoscopic eradication therapy. Experts in this field will review updated guidelines, discuss knowledge gaps and provide practical advice for the practicing clinicians…
Advances in Diagnosis and Management of Eosinophilic Esophagitis
SOCIETY: AGA The future of clinical approach to eosinophilic esophagitis
Debates in Eosinophilic Esophagitis: From Diapers to Depends
LIVE STREAM SESSION The great debates on EoE will review controversial areas in EoE management relevant to both pediatric and adult patients, including whether long-term therapy is necessary for the asymptomatic patient with minimally involved EoE, whether a full four/six food elimination diet is n…
Portal Hypertension, Complications of Cirrhosis, and GI Bleeding
DEVELOPMENT AND VALIDATION OF THE HOPE-EVL SCORE: A SCORING SYSTEM FOR IN-HOSPITAL MORTALITY FOLLOWING BAND LIGATION IN ESOPHAGEAL VARICEAL BLEEDING
